The article discusses how low-beta growth stocks like boston scientific and mastercard may perform better as market volatility persists due to Trump's new tariff policies. trivariate research provides insights on these stocks amidst investor caution.

Mentioned as a low-beta growth stock that has risen 56% in the last 12 months.

Highlighted as a low-beta growth idea, shares have risen 19% over the last 12 months.

The research firm providing insights about low-beta growth stocks.

Founder of trivariate research, providing insights on stock performance.

Highlighted low-beta growth stock that surged 40% in the past year.